HIV enters the brain and doesn't leave, drugs intended to reduce brain inflammation increase virus levels
HIV can damage the brain and cause memory and cognitive problems. And once HIV enters the brain, it does not leave.
Jun 8, 2026
0
6
Amino Acids, Peptides, and Proteins: News and Research on Antibodies, Monoclonal
MeSH tree: D12.776.377.715.548.114.224
New drug cuts relapse risk by half in rare immune disorder trial
Stanford Medicine researchers and their colleagues found that a new drug, obexelimab, significantly reduces the risk of relapse in patients with IgG4-related disease, a rare chronic immune condition often misdiagnosed as ...
Jun 4, 2026
0
11
FDA approves Enhertu as neoadjuvant, adjuvant treatment for breast cancer
The U.S. Food and Drug Administration has approved AstraZeneca's Enhertu (fam-trastuzumab deruxtecan-nxki) for both the neoadjuvant and adjuvant treatment of patients with human epidermal growth factor receptor 2 (HER2)-positive ...
May 25, 2026
0
10
Clinical trial tests virus-immunotherapy combination for neuroendocrine tumors
A Phase I clinical trial is testing whether a tumor-targeting virus can help immunotherapy work more effectively against aggressive neuroendocrine tumors that often resist treatment. Researchers at Sylvester Comprehensive ...
May 21, 2026
0
4
FDA blocked melanoma drug as confusion reigned under Makary
The U.S. Food and Drug Administration's decision to withhold approval of a new skin cancer treatment fell like a hammer on doctors who treat melanoma and patients who saw that the drug had prolonged the lives of a third of ...
May 18, 2026
0
7
Trump promised cheaper drugs. Some prices dropped. Many others shot up
Since his second term started, President Donald Trump has announced, negotiated or floated a flurry of initiatives aimed at taming the excesses of the pharmaceutical industry.
May 12, 2026
0
7
Study suggests immunotherapy may strengthen treatment for aggressive prostate cancer
Researchers at Moffitt Cancer Center report encouraging early results from a phase 2 study examining whether immunotherapy can improve results when added to a radiotherapy-based treatment regimen for men with aggressive prostate ...
May 12, 2026
0
9
Cellular neighborhoods inside tumors may predict which patients with melanoma benefit from combination immunotherapy
A new UCLA Health Jonsson Comprehensive Cancer Center study suggests that the way immune cells are organized inside melanoma tumors may help researchers better understand which patients will benefit from combination immunotherapy ...
Apr 22, 2026
0
3
Intralesional nivolumab may be effective against precancerous oral lesions, Phase I trial results indicate
Injecting nivolumab (Opdivo) directly into precancerous oral lesions led to a reduction in lesion size and allowed some patients to avoid surgery, according to research from a Phase I clinical trial presented at the American ...
Apr 21, 2026
0
13
Report finds drug prices rising despite pricing deals
A new U.S. Senate report, released by Sen. Bernie Sanders, found that drug companies involved in price deals with President Donald Trump have continued to raise prices on hundreds of meds.
Apr 20, 2026
0
5
